Contract manufacturing deals for drugs marketed in US shift to Europe: GlobalData
Biopharma companies are increasingly choosing to outsource manufacturing for the U.S. market to European facilities, finds data and analytics firm GlobalData.
Read the full article on the original site.
Read Full Article